LIBRIO 15mg price in UAE

Overview

Welcome to Dwaey, specifically on LIBRIO 15mg Tablet page.
This medicine contains an important and useful components, as it consists of Aripiprazole.
LIBRIO 15mg is available in the market in concentration 15mg/Tablet and in the form of Tablet.

NEOPHARMA is the producer of LIBRIO 15mg and it is imported from UAE, The most popular alternatives of LIBRIO 15mg are listed downward .

Mode Of Action

Aripiprazole acts as a partial agonist at D2 and 5-HT1A receptors and as an antagonist at 5-HT2A receptors.

Indication

Major depressive disorder
Schizophrenia
Acute manic episodes of bipolar disorder
Agitation
Irritability in autism

Precaution

Patients with known CV diseases (e.g. history of MI, IHD, CCF or conduction abnormalities), cerebrovascular diseases or conditions which would predispose patients to hypotension; Alzheimer's disease and dementia. Caution when operating hazardous machinery, including automobiles when taking aripiprazole. Pregnancy. Lactation: Excreted in human breast milk; a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother

Side Effects

>10% Weight gain (8-30%)
Headache (27%)
Agitation (19%)
Insomnia (18%)
Anxiety (17%)
Nausea and vomiting (11-15%)
Akathisia (10-13%)
Lightheadedness (11%)
Constipation (10-11%) 1-10% Dizziness (10%)
Dyspepsia (9%)
Somnolence (5-8%)
Fatigue (6%)
Restlessness (6%)
Tremor (6%)
Dry mouth/xerostomia (5%)
Extrapyramidal disorder (5%)
Orthostatic hypotension (1-5%)
Musculoskeletal stiffness (4%)
Abdominal discomfort (3%)
Blurred vision (3%)
Cough (3%)
Pain (3%)
Myalgia (2%)
Rash
Rhinitis <1% Altered mental status
Autonomic instability
Dysphagia
Hyperpyrexia
Muscle rigidity
Neuroleptic malignant syndrome (NMS)
Seizure
Tardive dyskinesia

Contra indication

Hypersensitivity. Lactation. Children <18 yr.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Drugs that induce CYP3A4 (e.g. carbamazepine) could cause an increase in aripiprazole clearance and lower blood levels. Inhibitors of CYP3A4 (e.g. ketoconazole) or CYP2D6 (e.g. quinidine, fluoxetine or paroxetine) can inhibit aripiprazole elimination and cause increased blood levels. Increased CNS depression with ethanol.